Retrospective Drug Utilization Review: Incidence of Clinically Relevant Potential Drug-Drug Interactions in a Large Ambulatory Population
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the incidence of clinically relevant potential drug-drug interactions (DDIs) in a large population of ambulatory patients utilizing a computerized, retrospective drug utilization review (DUR) program followed by clinical pharmacist audit. METHODS: The drug claims database included approximately 2.9 million patients with more than 30 million prescriptions dispensed in the 12-month period from September 2001 through August 2002. Cases were identified by a computerized, retrospective DUR program with embedded triggers to detect 69 prespecified potentially serious DDIs, with "serious" defined as an interaction that would likely require a change in therapy or use of additional clinical or laboratory monitoring. Two types of automated, computerized assessments were conducted: the first simply detected coprescribed drug pairs, and the second assessment used more sophisticated filters to reduce false positive alerts for coprescribed drug pairs. Clinical pharmacist audit then determined the final incidence of clinically relevant warnings; in this audit, coprescribed drug pairs were defined as clinically relevant if they could cause potentially serious DDIs. RESULTS: Eighteen drug pairs had insufficient cases for inclusion, leaving 51 drug pairs for evaluation. A total of 244,703 cases of potential DDIs were identified (0.8% of total prescription claims) by simple automated screens. More sophisticated DDI filters reduced the 244,703 potential DDIs by 70.8%, to a total of 65,544 pairs (0.2% of total prescription claims). Clinical pharmacist review reduced the number of potential DDIs by an additional 80.6%, to 12,722 drug pairs (0.04% of total prescription claims) deemed clinically relevant. The combination of sophisticated DDI filters and clinical pharmacist review reduced the incidence of potentially serious DDIs by 94.3%. CONCLUSION: The incidence of potentially serious DDIs is relatively low (less than 1%) among ambulatory patients; however, the incidence depends on the method of case finding. Retrospective DUR programs, especially those with additional automated filters or that utilize additional pharmacist review, appear to be important screening tools in determining true rates of coprescribed drug pairs that can lead to potentially serious DDIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
Relationship between medication errors and adverse drug events
Bates, D. W., Boyle, D. L., Vliet, M. B. V., Schneider, J., & Leape, L. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02600255 · Cited by 981
ORCA: OpeRational ClassificAtion of Drug Interactions
Hansten, P. D., Horn, J. R., & Hazlet, T. K. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31244-x · Cited by 98 · cited 1×
“One concern when developing such categorizations is that there is no singular consensus about a standardized classification scheme.(48) Indeed, while clinicians will no doubt disagree about clinical significance, there is also a lack of uniformity about potential severity of DDIs across commonly used reference materia…”
Background
Cited by
Risks of Self-Medication Practices
Ruiz, M. (2010) · Current Drug Safety · doi:10.2174/157488610792245966 · Cited by 506
Rayo, M. F., & Moffatt-Bruce, S. D. (2015) · BMJ Quality & Safety · doi:10.1136/bmjqs-2014-003373 · Cited by 115
Practitioners’ views on computerized drug-drug interaction alerts in the VA system
Ko, Y., Abarca, J., Malone, D. C., Dare, D. C., Geraets, D., Houranieh, A., Jones, W. N., Nichol, W. P., Schepers, G. P., & Wilhardt, M. (2007) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m2224 · Cited by 102
(2007) · PubMed · Cited by 93
What, if all alerts were specific - estimating the potential impact on drug interaction alert burden
Seidling, H. M., Klein, U., Schaier, M., Czock, D., Theile, D., Pruszydlo, M. G., Kaltschmidt, J., Mikus, G., & Haefeli, W. E. (2014) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2013.12.006 · Cited by 91
Metadata
- Authors
- Peng, C. C., Glassman, P. A., Marks, I. R., Fowler, C., Castiglione, B., & Good, C. B.
- Venue
- Journal of Managed Care Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2003-11
- Volume
- 9
- Issue
- 6
- Pages
- 513-522
- ISSN
- 1083-4087 (ISSN-L)
- 1944-706X
- OpenAlex
- W2157891764
- Cited by
- 89
- References
- 4
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retrospective Drug Utilization Review: Incidence of Clinically Relevant Potential Drug-Drug Interactions in a Large Ambulatory Population. https://app.cochat.ai/papers/10.18553/jmcp.2003.9.6.513
- The paper
- Peng, C. C., Glassman, P. A., Marks, I. R., Fowler, C., Castiglione, B., & Good, C. B. (2003). Retrospective Drug Utilization Review: Incidence of Clinically Relevant Potential Drug-Drug Interactions in a Large Ambulatory Population. Journal of Managed Care Pharmacy. https://doi.org/10.18553/jmcp.2003.9.6.513
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.